700 per cent returns: Board announced stock split of equity shares; FIIs increased stake!

700 per cent returns: Board announced stock split of equity shares; FIIs increased stake!

Praveenkumar Yadav
/ Categories: Trending, Mindshare

Shares of this company have gained more than 40 per cent in the last six months.

J B Chemicals & Pharmaceuticals Limited informed in the exchange filing that the company’s board has approved a Split or Sub-Division of 1(One) equity share having a face value of Rs 2/- (Rupees Two Only) each into 2(Two) equity shares having a face value of Rs 1/- (Rupees One Only) each. The record date for the sub-division of the equity shares is fixed on, September 18, 2023.

J B Chemicals & Pharmaceuticals Limited has delivered multibagger returns to its shareholders in the last three years. During this period, shares of J B Chemicals & Pharmaceuticals Limited surged from Rs 784.45 on September 04, 2020, to Rs 2857.75 on August 30, 2023, an increase of about 260 per cent in a one-year holding period. In the last five years, the shares of the company gained over 700 per cent.

Furthermore, in Q1FY24, the company posted strong Quarterly Results. The revenue of the company stood at Rs 896.20 crore which increased by 14.19 per cent YoY. The operating profit of the company stood at Rs 237.74 crore, which increased by 36.91 per cent YoY, while the PAT of the company increased by 35.29 per cent YoY, staying at Rs 142.32 crore. In Q1FY24, FIIs increased their stake in the company from 8.62 per cent to 9.53 per cent.

J.B. Chemicals and Pharmaceuticals Limited is one of India's leading pharmaceutical companies. The company manufactures a wide range of pharmaceutical formulation specialities, radio-diagnostics, APIs and intermediates. The manufacturing units are in Ankleshwar, Panoli and Daman.

The stock has shown tremendous growth and investors should keep a close eye on this stock.

DSIJ's DSIJ's ‘Mid Bridge’ service recommends well researched Mid-Cap stocks for smart investing. If this interests you, do download the service details here.

Previous Article Multibagger penny stock under Rs 15: This micro-cap company collaborates with Kriti Kapoor for the upcoming film; know more here!
Next Article Watch out for these penny stocks locked in the upper circuit on August 30
Rate this article:
4.1

DALAL STREET INVESTMENT JOURNAL - DEMOCRATIZING WEALTH CREATION

Principal Officer: Mr. Shashikant Singh,
Email: principalofficer@dsij.in
Tel: (+91)-20-66663800

Compliance Officer: Mr. Rajesh Padode
Email: complianceofficer@dsij.in
Tel: (+91)-20-66663800

Grievance Officer: Mr. Rajesh Padode
Email: service@dsij.in
Tel: (+91)-20-66663800

Corresponding SEBI regional/local office address- SEBI Bhavan BKC, Plot No.C4-A, 'G' Block, Bandra-Kurla Complex, Bandra (East), Mumbai - 400051, Maharashtra.
Tel: +91-22-26449000 / 40459000 | Fax : +91-22-26449019-22 / 40459019-22 | E-mail : sebi@sebi.gov.in | Toll Free Investor Helpline: 1800 22 7575 | SEBI SCORES | SMARTODR